DaVita Inc. insider Kathleen Alyce Waters reported a series of common stock sales dated June 15, 2026, according to a Form 4 filed June 17. The filing describes open-market sales of DaVita common stock, reported as sale transactions, involving a total of 131,054 shares and generating approximately $27.4 million in gross proceeds based on the weighted-average prices disclosed. The largest reported transaction covered 115,649 shares sold at a weighted-average price of $209.167 per share. A separate sale of 6,455 shares was also reported at the same weighted-average price. For those sales, the reported execution prices ranged from $206.115 to $210.410 per share. Waters also sold 8,950 shares at a weighted-average price of $207.844, with executions ranging from $206.115 to $208.780 per share. The filing notes that the sales were reported using weighted-average prices and that Waters undertakes to provide detailed price-by-price information upon request to the SEC staff, DaVita, or a DaVita security holder. One of the reported sale lines was made pursuant to a Rule 10b5-.
Stock detail
DaVita (DVA) stock price, chart, and key data
View DaVita stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
DaVita
DVA · XNYS
-$13.91 (-6.03%) past day
$216.90
Overnight $212.95 (-1.82%)
Key metrics
Financials
Quarterly revenue, profitability, and balance-sheet snapshot
Day range
$230.81 - $237.74
Close price
$234.27
Market cap
$15B
P/E ratio
20.25
About the company
DaVita Inc.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Ro Khanna
democrat · House · CA-17
- Sell$1,001 / $8,001 / $15,000
- Buy$1,000 / $8,000 / $15,000
- Sell$1,000 / $8,000 / $15,000
- Buy$1,000 / $8,000 / $15,000
#2Tommy Tuberville
republican · Senate · AL
- Sell$1,001 / $8,001 / $15,000
- Sell$1,001 / $8,001 / $15,000
#3Ro Khanna
democrat · House · CA-17
- Sell$1,000 / $8,000 / $15,000
- Buy$1,000 / $8,000 / $15,000
#4Alan Armstrong
- Buy$1,001 / $8,001 / $15,000
#5Julie Johnson
democrat · House · TX-32
- Sell$1,001 / $8,001 / $15,000
#6Rob Bresnahan
republican · House · PA-8
#7Gilbert Cisneros
democrat · House · CA-31
#8Donald J Trump
republican · Executive
Market action
A concise summary of the latest filing, transaction, or market-moving item.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app